Search research articles
Contact Us
Filters
Showing results (131-140 of 178) with videos related to
Page
of 18
Sort By:
ESMO Open
|
February 6, 2026
Inadequate ovarian function suppression and endocrine therapy manipulations in premenopausal patients with early breast cancer on adjuvant LHRH agonist and aromatase inhibitor: a cohort study
C Valenza, J D Etessami, M Milano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2011
Outcome of special types of luminal breast cancer
M Colleoni, N Rotmensz, P Maisonneuve, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2011
Breast cancer subtypes and outcome after local and regional relapse
E Montagna, V Bagnardi, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 6, 1999
Primary chemotherapy in operable breast cancer with favorable prognostic factors: a pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN)
F Nolè, I Minchella, M Colleoni, et al.
Breast Cancer Research and Treatment
|
April 1, 2011
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes
G Cancello, P Maisonneuve, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2015
Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial
E Munzone, A Giobbie-Hurder, B A Gusterson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 12, 2020
Identifying oncogenic drivers associated with increased risk of late distant recurrence in postmenopausal, estrogen receptor-positive, HER2-negative early breast cancer: results from the BIG 1-98 study
S J Luen, R Asher, C K Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 29, 2000
Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer
G Ferretti, G Curigliano, U Pastorino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2007
CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials
A Keshaviah, S Dellapasqua, N Rotmensz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2001
Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer
M Colleoni, S Gelber, A S Coates, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 178) with videos related to
Sort By:
Page
of 18
ESMO Open
|
February 6, 2026
Inadequate ovarian function suppression and endocrine therapy manipulations in premenopausal patients with early breast cancer on adjuvant LHRH agonist and aromatase inhibitor: a cohort study
C Valenza, J D Etessami, M Milano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 1, 2011
Outcome of special types of luminal breast cancer
M Colleoni, N Rotmensz, P Maisonneuve, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 29, 2011
Breast cancer subtypes and outcome after local and regional relapse
E Montagna, V Bagnardi, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 6, 1999
Primary chemotherapy in operable breast cancer with favorable prognostic factors: a pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN)
F Nolè, I Minchella, M Colleoni, et al.
Breast Cancer Research and Treatment
|
April 1, 2011
Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes
G Cancello, P Maisonneuve, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2015
Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial
E Munzone, A Giobbie-Hurder, B A Gusterson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 12, 2020
Identifying oncogenic drivers associated with increased risk of late distant recurrence in postmenopausal, estrogen receptor-positive, HER2-negative early breast cancer: results from the BIG 1-98 study
S J Luen, R Asher, C K Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 29, 2000
Detection by denaturant gradient gel electrophoresis of tumor-specific mutations in biopsies and relative bronchoalveolar lavage fluid from resectable non-small cell lung cancer
G Ferretti, G Curigliano, U Pastorino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 24, 2007
CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials
A Keshaviah, S Dellapasqua, N Rotmensz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 2, 2001
Influence of endocrine-related factors on response to perioperative chemotherapy for patients with node-negative breast cancer
M Colleoni, S Gelber, A S Coates, et al.
Page
of 18